Esophageal Neoplasms: all 1,631 studies
Page 14 of 17. Open to participants first (469), then studies with results posted, then the rest; newest registration first within each.
- PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric CancerCompletedNCT01613950Phase 1
- Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus CancerTerminatedNCT01608464Phase 2
- Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal CancerCompletedNCT01605305Phase 2
- Endoscopic Resection or Ablation for Patients With Dysplasia or Cancer Requiring Treatment of Barrett's EsophagusTerminatedNCT01572987Not applicable
- Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT01561014Phase 1
- Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal CancerCompletedNCT01558648
- Endoscopic Ultrasound Plus Submucosal Injection for Early Esophageal CancerStatus unknownNCT01555801Not applicable
- Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal CancerStatus unknownNCT01551641Phase 2
- Involved Field Irradiation (IFI) Versus Elective Nodal Irradiation (ENI) for Esophageal CancerCompletedNCT01551589Not applicable
- Robot-assisted Thoraco-laparoscopic Esophagectomy Versus Open Transthoracic EsophagectomyCompletedNCT01544790Phase 3
- Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival AnalysisCompletedNCT01525953
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsCompletedNCT01522820Phase 1
- Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) TrialActive, not recruitingNCT01512589Phase 2
- Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric AdenocarcinomasCompletedNCT01504256Phase 2
- Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal CancerCompletedNCT01490749Phase 1
- mFOLFIRI Combine With Nimotuzumab Second Line Chemotherapy for Squamous-cell Carcinoma of the EsophagusStatus unknownNCT01486992Phase 2
- Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or StomachCompletedNCT01472029Phase 2
- Quality of Life and Dysphagia Following Palliative Stenting in Esophageal CancerTerminatedNCT01471249
- Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical TrialCompletedNCT01463605Phase 2
- Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal CancerStatus unknownNCT01463501Phase 2
- Radiotherapy & Olaparib in COmbination for Carcinoma of the OesophagusStatus unknownNCT01460888Phase 1
- A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and CisplatinStatus unknownNCT01444547Phase 2
- MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal AdenocarcinomaCompletedNCT01443065Phase 2
- Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ AdenocarcinomaCompletedNCT01404156Phase 2/3
- Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal CancerCompletedNCT01386346Phase 1
- Efficacy and Safety of Panitumumab Combined With Docetaxel and Cisplatin as a First-line Treatment of Advanced Gastric or Gastroesophageal Junction AdenocarcinomaStatus unknownNCT01379807Phase 2
- Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer PatientsStatus unknownNCT01368419Phase 2
- Optimal Management of Malignant DysphagiaTerminatedNCT01366833Not applicable
- Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney DysfunctionActive, not recruitingNCT01366144Phase 1
- Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal JunctionCompletedNCT01360086Phase 2
- Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric CancerStatus unknownNCT01359397Phase 2
- Health-related Quality of Life of Patients With Esophageal Cancer After SurgeryStatus unknownNCT01349517Phase 2
- Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the OesophagusCompletedNCT01348217Phase 2/3
- The Effect of Chemotherapy and Surgery for Cancer on Exercise CapacityCompletedNCT01325883
- Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the EsophagusWithdrawnNCT01301495Phase 2
- Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal CancerStatus unknownNCT01291823Phase 2
- Sequential FDG-PET (Positron Emission Tomography) and Induction Chemotherapy in Locally Advanced Adenocarcinoma of the Esophagogastric Junction (AEG)TerminatedNCT01271322Phase 2
- Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction ChemoradiotherapyCompletedNCT01269970
- Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)Status unknownNCT01267578Phase 2
- The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic SurgeryCompletedNCT01267305Not applicable
- Study of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based TreatmentCompletedNCT01262482Phase 2
- Radio-chemotherapy With or Without Panitumumab (Vectibix®) in Irresectable Squamous Cell Carcinoma or Adenocarcinoma of the OesophagusTerminatedNCT01262183Phase 2
- Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally InvasiveCompletedNCT01262040Not applicable
- Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural MesotheliomasTerminatedNCT01258868Phase 1
- Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck CancerStatus unknownNCT01254591Not applicable
- Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionTerminatedNCT01249443Phase 1
- A Study of Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal CancerCompletedNCT01249352Phase 2/3
- Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer.TerminatedNCT01248299Phase 2
- Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After ChemotherapyCompletedNCT01243398Phase 3
- Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of EsophagusCompletedNCT01225523Phase 1
- Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological CancerCompletedNCT01216813
- Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal CancerStatus unknownNCT01216527Phase 3
- Case Analysis on Real Life Incidence of Photodynamic Therapy (PDT) Safety OutcomesWithdrawnNCT01203163
- Endoscopic Submucosal Dissection in Upper Gastrointestinal Canal With HybridKnifeStatus unknownNCT01185483
- S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal CancerCompletedNCT01175460Phase 1
- S-1 and Radiotherapy in Elderly Patients With Esophageal CancerCompletedNCT01175447Phase 1
- Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT01172028Phase 1
- A Retrospective Analysis of Statin Use and Outcome After Thoracic Cancer SurgeryCompletedNCT01169051
- Sorafenib. ICORG 06-41, V4CompletedNCT01158287Phase 2
- PET-CT Based Radiotherapy in Esophageal Cancer PatientsCompletedNCT01156831
- A Trial to Compare Preoperative Chemoradiation and Surgery Versus Surgery Alone in Squamous Cell Carcinoma of OesophagusStatus unknownNCT01151839Not applicable
- Trial of Lapatinib Versus Lapatinib With Capecitabine in Her2+ Metastatic Gastro-Esophageal CancerTerminatedNCT01145404Phase 2
- Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural MesotheliomasTerminatedNCT01143545Phase 1
- Hybrid-everted Versus Hand-sewn or Stapled Esophagogastrostomy in Prevention of Anastomotic StrictureCompletedNCT01139229Not applicable
- Improve the Treatment of Thoracic Esophageal CancerCompletedNCT01137123Phase 3
- Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction CancerTerminatedNCT01123473Phase 2
- Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by SurgeryCompletedNCT01107639Phase 3
- Simultaneous Integrated Boost (SIB) in Esophageal CancerCompletedNCT01102088Phase 1
- Chemoradiation and Panitumumab for Esophageal CancerCompletedNCT01077999Phase 2
- a Multicentric Randomized Controlled Trial of Self-Expandable Esophageal Radiation StentStatus unknownNCT01054274Phase 3
- Esophagectomy Associated Respiratory Complications: Ivor-Lewis Versus Sweet ApproachesStatus unknownNCT01053182Phase 3
- A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal CancerCompletedNCT01051479Phase 1
- Esophagectomy: Sweet Versus Ivor-Lewis (ESVIL) (ECTOP-2001)CompletedNCT01047111Not applicable
- Quality of Life With Esophageal Stent TrialStatus unknownNCT01044511Not applicable
- mFOLFIRI as the Second Line Chemotherapy for Advanced Esophageal Carcinoma After Failure of 1st Line Treatment of Paclitaxel/DDP : a Phase II Single Center Prospective Clinical TrialStatus unknownNCT01044420Phase 2
- Safety Study of Photodynamic Therapy Using Photocyanine Injection in Treating Patients With Malignant TumorsStatus unknownNCT01043016Phase 1
- Endobronchial Ultrasound (EBUS) for Nodal Staging in Esophageal CancerCompletedNCT01038544Not applicable
- Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal CancerStatus unknownNCT01038154Phase 4
- Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal CancerWithdrawnNCT01035437Not applicable
- Genetic and Environmental Risk Factors Related to Esophageal CancerActive, not recruitingNCT01035398
- Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Esophageal CarcinomaStatus unknownNCT01034683Phase 3
- Paclitaxel/Cisplatin/Fluorouracil Followed by Paclitaxel/Cisplatin/Radiotherapy and Esophagectomy for Esophageal CancerStatus unknownNCT01034332Phase 2
- Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal CancerStatus unknownNCT01034189Phase 2
- Surgery or Chemoradiation for Esophageal CancerCompletedNCT01032967Phase 3
- Safety Study of a Recombinant Protein Vaccine to Treat Esophageal CancerCompletedNCT01003808Phase 1
- A Study With Peptide Vaccination in Treating Patients With Esophageal CancerStatus unknownNCT00995358Phase 2
- Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett EsophagusStatus unknownNCT00987857Not applicable
- Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach CancerCompletedNCT00978549Phase 3
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid TumorsCompletedNCT00967577Phase 1
- Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal AdenocarcinomaStatus unknownNCT00964080Phase 1/2
- Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction CancerStatus unknownNCT00963092
- Cologne Esophageal Response Prediction Study (CERP-Study)CompletedNCT00953511Not applicable
- Nimotuzumab in Combination With Chemoradiation for Esophageal CancerCompletedNCT00950417Phase 1
- Open Versus Laparoscopically-assisted Esophagectomy for CancerCompletedNCT00937456Not applicable
- Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC)Status unknownNCT00915850Phase 1/2
- Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal CancerCompletedNCT00911092Phase 4
- A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal AdenocarcinomasCompletedNCT00909402Phase 1
- Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment TrialCompletedNCT00907543Not applicable
- Tethered Capsule Endoscope in Screening Participants for Barrett EsophagusStatus unknownNCT00903136Phase 1/2
- UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With CancerCompletedNCT00900094